Symbol: |
ANAPC13
|
Description: |
anaphase promoting complex subunit 13 [Source:HGNC Symbol;Acc:24540]
|
Location: |
Chr3:134196548-134205558[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:141
Gene |
Compound |
Gen_sig |
Exp_pattern |
ANAPC13 |
NSC 639211 |
0.02 |
Down |
ANAPC13 |
3,8,13,18-Pentaazapentacosane pentahydrochloride |
0.005 |
Down |
ANAPC13 |
Ethanedioic acid, mono(6-nitrobenzothiazol-2-yl)amide, mono[[2-(acetylhydrazino)-4-methylthiazol-5-yl]carbonyl] hydrazide |
0.008 |
Down |
ANAPC13 |
1,4-Naphthalenedione, 2-chloro-3-[[2-(2-fluorophenyl)- 1-oxoethyl]amino]- |
0.021 |
Down |
ANAPC13 |
3-Furancarbothioamide, [[3-(2-butenoxy)-4-methoxyphenyl]- 2-methyl- |
0.007 |
Down |
ANAPC13 |
NSC 650958 |
0.032 |
Down |
ANAPC13 |
1H-Pyrrolo[1,2-a]benzimidazole-5,8-dione, 6-(acetylamino)- 2,3-dihydro-3-[methoxy(acetyloxy)]-7-methyl- |
0.019 |
Down |
ANAPC13 |
NSC 656208 |
0.021 |
Down |
ANAPC13 |
NSC 656210 |
0.012 |
Down |
ANAPC13 |
NSC 660338 |
0.021 |
Down |
ANAPC13 |
2-bromo-8-methoxy-6-methyl-1,4-naphthoquinone |
0.018 |
Down |
ANAPC13 |
NSC 665106 |
0.036 |
Down |
ANAPC13 |
NSC 666063 |
0.005 |
Down |
ANAPC13 |
NSC 666112 |
0.025 |
Down |
ANAPC13 |
NSC 666854 |
0.033 |
Down |
Expression pattern: Sensitivity / Resistance
Total:10 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:16
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:22
Total:2 Current:1
[First] [Prev]  Next Last 
|